6505--Supplies - Radioactive Isotopes - Ann Arbor
Veterans Affairs · 250-NETWORK CONTRACT OFFICE 10 (36C250)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C25026Q0724_1 in this department, oldest first.
- Aug 5, 2026 · this noticeCombined Synopsis/Solicitation
- Oct 1, 2026Combined Synopsis/SolicitationOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
Full and open Competition RFQ for Radioactive Isotopes for the Ann Arbor VA and Toledo CBOC. See RFQ attached for details.
Who won similar work
6 award notices on SAM.gov in the last 24 months. Matched by: Same office (250-NETWORK CONTRACT OFFICE 10 (36C250)), same product/service code (PSC) 6505 and NAICS 325412.
Single-winner award sizes (6): middle half $558K to $4.0M, median $630K; range $135K to $5.4M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| PROGENICS PHARMACEUTICALS INC | 2 | $6.0M | May 8, 2026 |
| SOFIE Co. DULLES 20166 | 2 | $1.3M | Oct 1, 2026 |
| RLS (USA) INC. | 1 | $5.2M | Oct 1, 2026 |
| TRILLAMED LLC | 1 | $135K | Nov 27, 2024 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- Oct 1, 2026SOFIE Co. DULLES 20166$558K6505--PET MRI Radiopharmaceuticals, DetroitNo listed company matched (Materiality N/A)
- Oct 1, 2026RLS (USA) INC.$5.2M6505--Supplies - Radioactive Isotopes - Ann ArborNo listed company matched (Materiality N/A)
- May 8, 2026PROGENICS PHARMACEUTICALS INC$559K6505-- F-18 Pylarify - Radiopharmaceutical Cincinnati VAMC, 539C65197No listed company matched (Materiality N/A)
- Oct 1, 2025PROGENICS PHARMACEUTICALS INC$5.4M6505--Radiopharmaceutical Pylarify FSS BPANo listed company matched (Materiality N/A)
- Oct 1, 2025SOFIE Co. DULLES 20166$700K6505--PET MRI RadiopharmaceuticalsNo listed company matched (Materiality N/A)
- Nov 27, 2024TRILLAMED LLC$135K6505--Axumin Cerianna Nuclear Med Cleveland VAMC 541A50179No listed company matched (Materiality N/A)
Competitive landscape
For the 4 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.